Nikhil Wagle, MD, discusses how patient-centered research can lead to better treatment options for patients with inflammatory breast cancer. Dr. Wagle is the director of Count Me In, a nonprofit organization co-founded by Dana-Farber that is pursuing a new, patient-partnered approach to cancer research. This presentation was part of the Dana-Farber Inflammatory Breast Cancer Program 5th Annual Patient Forum in April 2022.
To learn more about Count Me In please visit https://www.dana-farber.org/research/featured-research/count-me-in.
For more information about Dana-Farber's Inflammatory Breast Cancer Program, please visit us at https://www.dana-farber.org/inflammatory-breast-cancer-program.